HomePASG • NASDAQ
add
Passage Bio Inc
Previous close
$8.10
Day range
$7.20 - $8.21
Year range
$5.12 - $20.00
Market cap
23.90M USD
Avg Volume
40.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.34M | -27.54% |
Net income | -12.98M | -2.03% |
Net profit margin | — | — |
Earnings per share | -4.09 | -2.25% |
EBITDA | -10.16M | 25.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 46.30M | -39.68% |
Total assets | 62.28M | -39.19% |
Total liabilities | 43.53M | 5.77% |
Total equity | 18.76M | — |
Shares outstanding | 3.21M | — |
Price to book | 1.38 | — |
Return on assets | -37.89% | — |
Return on capital | -52.64% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -12.98M | -2.03% |
Cash from operations | -6.48M | 23.27% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 9.00K | -80.85% |
Net change in cash | -6.47M | -222.51% |
Free cash flow | -3.37M | 19.46% |
About
Founded
2017
Headquarters
Website
Employees
24
